Limited accessibility to designs and results of Japanese large-scale clinical trials for cardiovascular diseases
<p>Abstract</p> <p>Background</p> <p>Clinical evidence is important for improving the treatment of patients by health care providers. In the study of cardiovascular diseases, large-scale clinical trials involving thousands of participants are required to evaluate the ri...
Main Authors: | Tsutani Kiichiro, Ueshima Kenji, Sawata Hiroshi |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-04-01
|
Series: | Trials |
Online Access: | http://www.trialsjournal.com/content/12/1/96 |
Similar Items
-
How Can the Evidence from Global Large-scale Clinical Trials for Cardiovascular Diseases be Improved?
by: Tsutani Kiichiro, et al.
Published: (2011-06-01) -
Funding and infrastructure among large-scale clinical trials examining cardiovascular diseases in Japan: evidence from a questionnaire survey
by: Sawata Hiroshi, et al.
Published: (2011-11-01) -
Use of Kampo diagnosis in randomized controlled trials of Kampo products in Japan: a systematic review.
by: Yoshiharu Motoo, et al.
Published: (2014-01-01) -
Compliance of Clinical Trial Protocols for Foods with Function Claims (FFC) in Japan: Consistency between Clinical Trial Registrations and Published Reports
by: Hiroharu Kamioka, et al.
Published: (2021-12-01) -
Clinical trial registration and publication in acupuncture studies: a systematic review
by: Yuto Matsuura, et al.
Published: (2020-03-01)